Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.
about
Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials.Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@en
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@nl
type
label
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@en
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@nl
prefLabel
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@en
Cost Evaluation of Irinotecan- ...... he UGT1A1*28 Patient Genotype.
@nl
P2093
P2860
P50
P356
P1476
Cost Evaluation of Irinotecan- ...... the UGT1A1*28 Patient Genotype
@en
P2093
A Buonadonna
F Innocenti
V Solfrini
P2860
P304
P356
10.1002/CPT.615
P407
P577
2017-03-20T00:00:00Z